Stock listing
BOATS:GENB Generate Biomedicines, Inc. Stock
US listing (BOATS) of Generate Biomedicines, Inc. · home listing NASDAQ:GENB
Follow Generate Biomedicines, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:GENB
$13.78 USD -0.40 (-2.8%)
Close on Nov 10, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GENB
- Day range
- $13.60 – $14.55 USDNov 10, 2026
- Volume
- 529,861 sharesNov 10, 2026
- Market cap
- $1.77B USDAt the close on Nov 10, 2026 · price × 128.4M shares outstanding
- Traded on an average day
- $18.39M USDMedian day 969,400 shares · last 3 months, Aug 10, 2026 – Nov 10, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GENB · Home | $13.78 USD | -0.40 (-2.8%) | 529,861 | $13.86 | $14.55 | $13.60 | $14.18 | Close on Nov 10, 2026 |
Daily closes
Last 3 months, Aug 10, 2026 – Nov 10, 2026 · NASDAQ:GENB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $13.78 | -0.40 | -2.8% | $13.86 | $14.55 | $13.60 | 529,861 | |
| $14.18 | +1.12 | +8.6% | $13.25 | $14.38 | $12.93 | 666,838 | |
| $13.06 | +0.49 | +3.9% | $12.90 | $13.17 | $12.47 | 632,115 | |
| $12.57 | -1.59 | -11.2% | $14.00 | $14.11 | $12.46 | 1,296,730 | |
| $14.16 | +0.31 | +2.2% | $14.27 | $14.34 | $13.40 | 636,267 | |
| $13.85 | +0.64 | +4.8% | $13.33 | $14.17 | $13.33 | 723,832 | |
| $13.21 | -1.25 | -8.6% | $14.28 | $14.64 | $13.18 | 744,521 | |
| $14.46 | -1.31 | -8.3% | $14.80 | $15.63 | $14.25 | 1,168,424 | |
| $15.77 | +0.39 | +2.5% | $15.45 | $16.46 | $15.32 | 1,740,905 | |
| $15.38 | +2.17 | +16.4% | $13.89 | $15.39 | $13.71 | 3,923,327 | |
| $13.21 | +0.86 | +7.0% | $12.35 | $13.39 | $12.20 | 740,237 | |
| $12.35 | -0.06 | -0.5% | $12.52 | $12.55 | $12.21 | 340,815 | |
| $12.41 | -0.38 | -3.0% | $12.75 | $12.94 | $12.20 | 295,554 | |
| $12.79 | -0.32 | -2.4% | $13.00 | $13.37 | $12.54 | 498,911 | |
| $13.11 | +0.21 | +1.6% | $13.04 | $13.21 | $12.80 | 421,212 | |
| $12.90 | +0.34 | +2.7% | $12.53 | $13.07 | $12.44 | 523,325 | |
| $12.56 | +0.47 | +3.9% | $12.20 | $12.85 | $12.12 | 675,260 | |
| $12.09 | -0.97 | -7.4% | $13.02 | $13.22 | $11.84 | 1,074,700 | |
| $13.06 | +0.54 | +4.3% | $12.53 | $13.16 | $12.43 | 974,900 | |
| $12.52 | +0.26 | +2.1% | $12.61 | $12.90 | $12.10 | 1,951,000 | |
| $12.26 | -1.58 | -11.4% | $13.75 | $13.75 | $12.25 | 930,700 | |
| $13.84 | -0.50 | -3.5% | $14.34 | $14.37 | $13.81 | 675,900 | |
| $14.34 | +0.35 | +2.5% | $14.06 | $14.86 | $13.94 | 903,100 | |
| $13.99 | +0.42 | +3.1% | $13.50 | $14.14 | $13.08 | 1,155,700 | |
| $13.57 | -0.23 | -1.7% | $13.59 | $13.99 | $13.35 | 926,300 | |
| $13.80 | -0.11 | -0.8% | $14.00 | $14.19 | $13.55 | 1,169,800 | |
| $13.91 | +0.22 | +1.6% | $13.71 | $14.06 | $13.45 | 1,119,600 | |
| $13.69 | -0.11 | -0.8% | $13.93 | $14.30 | $13.30 | 1,262,600 | |
| $13.80 | -1.22 | -8.1% | $14.79 | $14.99 | $13.77 | 1,391,800 | |
| $15.02 | -0.40 | -2.6% | $15.54 | $15.61 | $15.00 | 733,200 | |
| $15.42 | +0.51 | +3.4% | $14.90 | $15.51 | $14.65 | 594,600 | |
| $14.91 | -0.24 | -1.6% | $15.15 | $15.32 | $14.61 | 1,135,300 | |
| $15.15 | -0.84 | -5.3% | $16.04 | $16.10 | $15.03 | 1,266,700 | |
| $15.99 | -0.53 | -3.2% | $16.44 | $16.48 | $15.40 | 1,438,100 | |
| $16.52 | -0.94 | -5.4% | $17.44 | $17.59 | $16.46 | 1,424,700 | |
| $17.46 | +0.08 | +0.5% | $17.68 | $17.97 | $17.32 | 1,306,100 | |
| $17.38 | +0.24 | +1.4% | $17.46 | $17.68 | $17.11 | 1,393,700 | |
| $17.14 | +0.02 | +0.1% | $17.17 | $17.30 | $16.53 | 1,402,900 | |
| $17.12 | +1.44 | +9.2% | $16.04 | $17.83 | $16.04 | 2,204,800 | |
| $15.68 | -0.51 | -3.2% | $16.09 | $16.40 | $15.61 | 1,509,100 | |
| $16.19 | +0.19 | +1.2% | $15.83 | $16.27 | $15.55 | 959,200 | |
| $16.00 | +0.28 | +1.8% | $15.73 | $16.45 | $15.39 | 1,533,400 | |
| $15.72 | +0.33 | +2.1% | $15.44 | $15.88 | $15.32 | 666,000 | |
| $15.39 | -0.13 | -0.8% | $15.32 | $16.05 | $15.03 | 1,008,300 | |
| $15.52 | -0.38 | -2.4% | $15.80 | $16.23 | $15.20 | 977,900 | |
| $15.90 | -0.49 | -3.0% | $16.36 | $16.36 | $15.40 | 1,257,800 | |
| $16.39 | +0.05 | +0.3% | $16.39 | $16.62 | $15.98 | 724,700 | |
| $16.34 | +0.06 | +0.4% | $16.40 | $16.59 | $15.97 | 963,900 | |
| $16.28 | +0.49 | +3.1% | $15.75 | $16.78 | $15.69 | 892,500 | |
| $15.79 | +0.52 | +3.4% | $15.12 | $16.01 | $14.93 | 1,048,800 | |
| $15.27 | -0.06 | -0.4% | $15.27 | $15.63 | $14.77 | 1,551,900 | |
| $15.33 | -0.44 | -2.8% | $15.77 | $16.30 | $14.74 | 2,353,200 | |
| $15.77 | -0.37 | -2.3% | $17.11 | $17.47 | $15.71 | 2,856,600 | |
| $16.14 | -4.24 | -20.8% | $20.00 | $20.14 | $15.93 | 3,850,000 | |
| $20.38 | +2.66 | +15.0% | $17.67 | $22.67 | $17.38 | 4,692,301 | |
| $17.72 | +1.60 | +9.9% | $16.67 | $17.99 | $16.03 | 2,500,237 | |
| $16.12 | +0.13 | +0.8% | $16.10 | $16.70 | $15.91 | 830,800 | |
| $15.99 | -0.98 | -5.8% | $16.76 | $16.85 | $15.74 | 952,700 | |
| $16.97 | +0.89 | +5.5% | $16.47 | $17.62 | $16.09 | 1,390,000 | |
| $16.08 | +0.39 | +2.5% | $15.51 | $16.63 | $15.51 | 580,300 | |
| $15.69 | +0.05 | +0.3% | $15.63 | $15.75 | $15.03 | 745,900 | |
| $15.64 | +0.61 | +4.1% | $14.99 | $15.70 | $14.56 | 310,800 | |
| $15.03 | -0.06 | -0.4% | $15.20 | $15.48 | $14.90 | 503,200 | |
| $15.09 | +0.82 | +5.7% | $14.16 | $15.35 | $14.09 | 750,200 | |
| $14.27 | -0.45 | -3.1% | $14.53 | $14.63 | $14.17 | 443,900 | |
| $14.72 | +0.37 | +2.6% | $14.65 | $14.88 | $14.24 | 523,200 |
- Ticker
- BOATS:GENB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Generate Biomedicines to Participate in November Investor Conferences
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 57 slides
Latest news
Generate Biomedicines to Participate in November Investor Conferences
Oct 22, 2026
Closed $12.79 (-2.4%) on Oct 22, 2026
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Oct 13, 2026
Closed $12.52 (+2.1%) on Oct 14, 2026
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Oct 1, 2026
Closed $13.80 (-8.1%) on Oct 1, 2026
Generate Biomedicines Inc. to Participate in September Investor Conferences
Sep 8, 2026
Closed $15.90 (-3.0%) on Sep 8, 2026
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $13.89 (-4.1%) on Aug 6, 2026
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
May 28, 2026
Closed $13.12 (+0.2%) on May 29, 2026
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Closed $13.59 (-11.2%) on May 7, 2026
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
Feb 26, 2026
Closed $12.91 (-19.3%) on Feb 27, 2026
Financings
Public offering of common stock
Feb 27, 2026
Announced: US$400M · US$16 a share · Goldman Sachs & Co. LLC +4
Dealers: Goldman Sachs & Co. LLC (co-lead), Morgan Stanley (co-lead), Piper Sandler, Guggenheim Securities, Cantor
Decks
Investor Presentation (October 2026)
Investor deck · 57 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 55 slides · October 2026
Investor Presentation (June 2026)
Investor deck · 51 slides · June 2026
ERS Congress 2025 (Late Breaker)
Conference · 11 slides · 2025
Generate Biomedicines, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 8 in all · newest Oct 22, 2026 · oldest 2026
- Decks
- 5 decks · latest October 2026
Where Generate Biomedicines, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GENB · Home listing | NASDAQ | United States | USD |
| BOATS:GENB · This page | BOATS | United States | USD |
| BX Swiss:GENB | BX Swiss | Switzerland | CHF |
| BMV:GENB | BMV | Mexico | MXN |
Log in to ask 6ix AI your own questions about Generate Biomedicines, Inc.